Literature DB >> 3720865

Ocular fluorophotometry in the normal- and diabetic monkey.

C W Jones, J G Cunha-Vaz, R C Zeimer, M M Rusin, P W Langenberg, C M Vygantas, M O Tso, O Jonasson.   

Abstract

Normal- and diabetic rhesus monkeys without retinopathy demonstrable by ophthalmoscopy or fluorescein angiography were examined with ocular fluorophotometry to detect alterations in their blood-ocular barriers. All vitreous fluorophotometry values were corrected for fluorescence attributable to background levels and then normalized to a blood fluorescein level of 10 micrograms ml-1. Reproducibility studies demonstrated an average coefficient of variation of 0.17 for all animals combined. Insulin-dependent monkeys, both pancreatectomized and streptozotocin-treated, demonstrated significantly higher posterior vitreous fluorescence levels than either control animals or monkeys treated with streptozotocin that were not insulin-dependent. These results cannot be attributed to differences in fluorescein binding or to vitreous abnormalities. However, 14 out of 24 (58%) of the insulin-dependent animals exhibited posterior vitreous fluorescence values within two standard deviations of the control mean. No correlation was apparent between the vitreous values and age or duration of treatment. No difference in anterior chamber concentrations was found between groups after correction. Our results indicate that alterations in blood-retinal barrier can occur in insulin-dependent diabetic monkeys before development of retinopathy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720865     DOI: 10.1016/0014-4835(86)90006-0

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  2 in total

1.  Microangiopathic retinopathy in experimental diabetic monkeys.

Authors:  M O Tso; A Kurosawa; E Benhamou; A Bauman; J Jeffrey; O Jonasson
Journal:  Trans Am Ophthalmol Soc       Date:  1988

2.  Retinopathy in diabetic hypertensive monkeys: a pathologic study.

Authors:  E R Büchi; A Kurosawa; M O Tso
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-06       Impact factor: 3.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.